Investment in Cytomos Limited led by Archangels with participation from Old College Capital, Scottish Enterprise and British Business Bank. New investment will allow the Edinburgh-based biotechnology company to drive sales of its first commercial product, Celledonia™, built on its cell-analysis technology platform AuraCyt.

ADVISORS & FUNDERS